The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

SMP2 consortium

doi:10.1038/s41416-022-02107-8

The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

SMP2 consortium

Research output: Contribution to journal › Article › peer-review

21 Downloads (Pure)

Abstract

Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.

Original language	English
Pages (from-to)	161-164
Number of pages	4
Journal	British Journal of Cancer
Volume	128
Issue number	2
Early online date	4 Jan 2023
DOIs	https://doi.org/10.1038/s41416-022-02107-8
Publication status	Published - 19 Jan 2023

Bibliographical note

Funding:
This work has been funded by grants from CRUK to all clinical hospitals and molecular laboratories involved in the study (references: CRUK A26798, A22801, A22802, A22786, A22787, A26796, A22792, A22793, A22788, A22790, A26794, A22791, A26792, A22808, A26790, A22796, A22795, A22803, A26797, A22797, A22798, A22794, A22800, A31319, A31320, A31318).

Copyright:
© 2023. The Author(s).

Keywords

Humans
Carcinoma, Non-Small-Cell Lung/genetics
Lung Neoplasms/genetics
United Kingdom

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41416-022-02107-8Licence: Creative Commons: Attribution (CC BY)

CeroneM2023CancerFinal published version, 380 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{c8c5fb372c6a46d39b15b2414fb37451,

title = "The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care",

abstract = "Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.",

keywords = "Humans, Carcinoma, Non-Small-Cell Lung/genetics, Lung Neoplasms/genetics, United Kingdom",

author = "{SMP2 consortium} and Cerone, {Maria Antonietta} and Mills, {Tara C} and Rowena Sharpe and David McBride and Moira MacDonald and Suzanne MacMahon and Hood Mugalaasi and Pauline Rehal and Alessandro Rettino and Helen Roberts and Mark Ross and White, {Donald Edward} and John Peden and Janette Rawlinson and Ho, {Steffan N} and Simon Hollingsworth and Sanjay Popat and Gary Middleton and Peter Johnson and Charles Swanton",

note = "Funding: This work has been funded by grants from CRUK to all clinical hospitals and molecular laboratories involved in the study (references: CRUK A26798, A22801, A22802, A22786, A22787, A26796, A22792, A22793, A22788, A22790, A26794, A22791, A26792, A22808, A26790, A22796, A22795, A22803, A26797, A22797, A22798, A22794, A22800, A31319, A31320, A31318). Copyright: {\textcopyright} 2023. The Author(s).",

year = "2023",

month = jan,

day = "19",

doi = "10.1038/s41416-022-02107-8",

language = "English",

volume = "128",

pages = "161--164",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Cancer Research UK",

number = "2",

}

TY - JOUR

T1 - The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

AU - SMP2 consortium

AU - Cerone, Maria Antonietta

AU - Mills, Tara C

AU - Sharpe, Rowena

AU - McBride, David

AU - MacDonald, Moira

AU - MacMahon, Suzanne

AU - Mugalaasi, Hood

AU - Rehal, Pauline

AU - Rettino, Alessandro

AU - Roberts, Helen

AU - Ross, Mark

AU - White, Donald Edward

AU - Peden, John

AU - Rawlinson, Janette

AU - Ho, Steffan N

AU - Hollingsworth, Simon

AU - Popat, Sanjay

AU - Middleton, Gary

AU - Johnson, Peter

AU - Swanton, Charles

N1 - Funding: This work has been funded by grants from CRUK to all clinical hospitals and molecular laboratories involved in the study (references: CRUK A26798, A22801, A22802, A22786, A22787, A26796, A22792, A22793, A22788, A22790, A26794, A22791, A26792, A22808, A26790, A22796, A22795, A22803, A26797, A22797, A22798, A22794, A22800, A31319, A31320, A31318). Copyright: © 2023. The Author(s).

PY - 2023/1/19

Y1 - 2023/1/19

N2 - Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.

AB - Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.

KW - Humans

KW - Carcinoma, Non-Small-Cell Lung/genetics

KW - Lung Neoplasms/genetics

KW - United Kingdom

U2 - 10.1038/s41416-022-02107-8

DO - 10.1038/s41416-022-02107-8

M3 - Article

C2 - 36599918

SN - 0007-0920

VL - 128

SP - 161

EP - 164

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 2

ER -

The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this